Theodore Cohen
Articles
What's Up With Vical?
Vical Initiates Trial Of Therapeutic HSV-2 Vaccine
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV
Dynavax Initiates Phase I Trial In Its Asthma Program
Dendreon's Provenge: A Major Focus At The European Cancer Congress 2013
Vical's Herpes Vaccine: An Update
Dynavax: Assembling The A-Team
Vical's Allovectin Phase III Trial Results: Consider The Possibilities
European Committee Adopts Positive Opinion On Dendreon's Provenge
Vical And Astellas Pharma Initiate Phase III CMV Vaccine Study
Dynavax: FDA Asks For Additional Safety Data
Trading Ahead Of The SAC Capital Fire Sale
Dendreon: New Trial Sequencing Provenge With Xtandi To Begin Q4
ViroPharma's Maribavir: Rising Like Phoenix
Dendreon's Provenge Ads: Are They Working?
Amgen's And Vical's Melanoma Trials: Questions
Dynavax Surprises: Announces Strategic Global Operations Hire
Dendreon Jump-Starts Its New Direct-To-Consumer Ad Campaign
The Dendreon Bear Raid Of 2009: Chasing The Perpetrators
Dynavax: A Takeover Target?
Dynavax: The Path Forward
Dendreon: Startling Results Sequencing Provenge After Medivation's Xtandi
2013 GU: Dendreon's Neuvenge, A First Look At The Clinical Trial Results
2013 GU: Dendreon's Provenge Can Be Co-Administered With Johnson & Johnson's Zytiga
Vical's Herpes Vaccine: New Lab Results Confirm Move To The Clinic
Dendreon's Provenge: Update With The President Of The Large Urology Group Practice Association
Dendreon's Provenge: New Opinion On Sequencing Agents Released
Dynavax Initiates New Phase I Trial For Lymphomas
Dendreon Dodges A Bullet
Dendreon: New Provenge Trial Involves Drugs Shown To Shrink Tumors
Dynavax Crashes On Unexpected Panel Vote
Dynavax Shares Jump On Release Of FDA Briefing Materials